Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000758116 | SCV000886593 | uncertain significance | Phenylketonuria | 2018-12-10 | reviewed by expert panel | curation | The c.811C>T (p.His271Tyr) variant in PAH has been reported in 2 unrelated PKU patients. BH4 deficiencies not assessed. (PMID: 9012412) A deleterious effect is predicted in SIFT, Polyphen2, MutationTaster, and REVEL=0.978. This variant has an extremely low frequency in ExAC, 1000G, ESP, and gnomAD (MAF=0.00001). . In summary, this variant meets criteria to be classified as uncertain significance for PAH. PAH-specific ACMG/AMP criteria applied: PM2, PP3, PP4. |
Gene |
RCV000089108 | SCV001758213 | uncertain significance | not provided | 2020-01-10 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Identified in two unrelated individuals with PKU, however a second variant not described in either patient (Tyfield et al., 1997); This variant is associated with the following publications: (PMID: 9012412, 25087612) |
Institute of Human Genetics, |
RCV004584351 | SCV002578038 | uncertain significance | See cases | 2021-12-08 | criteria provided, single submitter | clinical testing | ACMG categories: PM1,PM2,PP3,BP1 |
Labcorp Genetics |
RCV000758116 | SCV003441283 | likely pathogenic | Phenylketonuria | 2023-09-15 | criteria provided, single submitter | clinical testing | This sequence change replaces histidine, which is basic and polar, with tyrosine, which is neutral and polar, at codon 271 of the PAH protein (p.His271Tyr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with phenylketonuria (PMID: 9012412). ClinVar contains an entry for this variant (Variation ID: 102849). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PAH protein function. This variant disrupts the p.His271 amino acid residue in PAH. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 18299955). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
De |
RCV000089108 | SCV000119715 | not provided | not provided | no assertion provided | not provided | ||
Natera, |
RCV000758116 | SCV002088643 | uncertain significance | Phenylketonuria | 2020-10-16 | no assertion criteria provided | clinical testing |